CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $35,234,659
- in 11 filings, $35.2M under 10b5-1 plans
Net −$35,234,659. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$905K Chief Financial Officer sold 4% of stake
- Mercier Johanna −$901K Chief Comm & Corp Aff Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-10 | Burkhart Erin SVP, Controllership | Grant or award · Non-qualified Stock Option (Right to Buy) | +5,455 | 5,455 | ||
| 2026-03-10 | Mercier Johanna Chief Comm & Corp Aff Officer | Option exercise | +6,617 | 137,995 | ||
| 2026-03-10 | Mercier Johanna Chief Comm & Corp Aff Officer | Shares withheld for taxes | −3,216 | $148.56 | $478K | 134,779 |
| 2026-03-10 | Mercier Johanna Chief Comm & Corp Aff Officer | Option exercise · Restricted Stock Unit | −6,617 | 21,057 | ||
| 2026-03-10 | Mercier Johanna Chief Comm & Corp Aff Officer | Grant or award · Restricted Stock Unit | +9,590 | 30,647 | ||
| 2026-03-10 | Mercier Johanna Chief Comm & Corp Aff Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +35,880 | 35,880 | ||
| 2026-03-10 | Berger Dietmar Chief Medical Officer | Option exercise | +2,133 | 20,045 | ||
| 2026-03-10 | Berger Dietmar Chief Medical Officer | Shares withheld for taxes | −1,063 | $148.56 | $158K | 18,982 |
| 2026-03-10 | Berger Dietmar Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,133 | 39,046 | ||
| 2026-03-10 | Berger Dietmar Chief Medical Officer | Grant or award · Restricted Stock Unit | +8,415 | 47,461 | ||
| 2026-03-10 | Berger Dietmar Chief Medical Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +31,475 | 31,475 | ||
| 2026-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +20,026 | 662,334 | ||
| 2026-03-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −9,767 | $148.56 | $1.5M | 652,567 |
| 2026-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −20,026 | 68,044 | ||
| 2026-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Restricted Stock Unit | +32,815 | 100,859 | ||
| 2026-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Non-qualified Stock Option (Right to Buy) | +122,755 | 122,755 | ||
| 2026-03-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +6,469 | 185,338 | ||
| 2026-03-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −3,147 | $148.56 | $468K | 182,191 |
| 2026-03-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −6,469 | 21,057 | ||
| 2026-03-10 | Dickinson Andrew D Chief Financial Officer | Grant or award · Restricted Stock Unit | +9,590 | 30,647 |
Page 8 of 30 · 584 trades